Fig. 2From: Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysisROC curve of using SUVmax to predict disease progression of individual lesion. A SUV max of 4.4 has a 70% sensitivity and 71% specificity of predicting progressive disease of the individual lesion. The ROC AUC is 0.734 (95% CI 0.602–0.865, p = 0.004)Back to article page